ArticleFrontiers in cell and developmental biology2022

Applicability of Anticancer Drugs for the Triple-Negative Breast Cancer Based on Homologous Recombination Repair Deficiency.

Gaoming Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.